agilon health, inc.
AGLNYSECIK 1831097HealthcareFiscal year ends Dec 31
Reports and events: 89 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0516:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-053355 |
| 2026-08-0516:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053328 |
| 2026-07-2217:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-049080 |
| 2026-06-0316:31 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-040370 |
| 2026-05-0616:11 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-031270 |
| 2026-05-0616:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-031254 |
| 2026-04-2716:18 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-027512 |
| 2026-04-2216:49 ET | DEF 14A | Proxy statementPeriod 2026-06-02 | 0001628280-26-026544 |
| 2026-03-3017:43 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-26-022074 |
| 2026-03-1816:06 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-019406 |
| 2026-02-2516:12 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-011655 |
| 2026-02-2516:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-011630 |
| 2026-02-1816:24 ET | DEF 14A | Proxy statementPeriod 2026-03-17 | 0001140361-26-006007 |
| 2026-02-1216:09 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-26-007671 |
| 2026-01-0716:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-001168 |
| 2025-11-0707:03 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-050412 |
| 2025-11-0416:12 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-048839 |
| 2025-11-0416:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-048815 |
| 2025-08-0416:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-037430 |
| 2025-08-0416:12 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure | 0001628280-25-037426 |
| 2025-05-3016:43 ET | 8-K | 5.07 Shareholder vote results | 0001628280-25-028631 |
| 2025-05-0616:12 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-022691 |
| 2025-05-0616:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-022679 |
| 2025-04-1717:05 ET | DEF 14A | Proxy statementPeriod 2025-05-28 | 0001140361-25-014418 |
| 2025-02-2516:06 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-007721 |
| 2025-02-2516:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-007716 |
| 2024-12-0516:02 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-050056 |
| 2024-11-1908:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-048345 |
| 2024-11-0716:16 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-046286 |
| 2024-11-0716:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-046267 |
| 2024-08-0616:08 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-035179 |
| 2024-08-0616:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-035171 |
| 2024-06-0508:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-026758 |
| 2024-06-0316:15 ET | 8-K | 5.07 Shareholder vote results | 0001628280-24-026327 |
| 2024-05-0716:09 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-021088 |
| 2024-05-0716:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-021075 |
| 2024-04-1817:07 ET | DEF 14A | Proxy statementPeriod 2024-05-29 | 0001140361-24-020533 |
| 2024-02-2716:22 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-007242 |
| 2024-02-2716:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-007195 |
| 2024-02-0816:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-003867 |
| 2024-01-0506:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-000518 |
| 2024-01-0506:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-000516 |
| 2023-11-1407:58 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-038794 |
| 2023-11-0216:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628280-23-036378 |
| 2023-11-0216:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-036376 |
| 2023-08-1616:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-214326 |
| 2023-08-0817:09 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001628280-23-028276 |
| 2023-08-0316:08 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001628280-23-027201 |
| 2023-08-0316:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-027194 |
| 2023-06-2609:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001019056-23-000285 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.